Complex Pharmacokinetics of a Humanized Antibody Against Human Amyloid Beta Peptide, Anti-Abeta Ab2, in Nonclinical Species

By Vugmeyster Yulia   Szklut Pam   Wensel David   Ross John   Xu Xin   Awwad Michel   Gill Davinder   Tchistiakov Lioudmila   Warner Garvin  

Pharmaceutical Research, Vol. 28, Iss. 7, 2011-07 ,pp. : 1696-1706

Springer Publishing Company

Access to resources Recommend Favorite

Abeta Immunotherapy and Other Means to Remove Amyloid

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 5, 2005-10 ,pp. : 569-573

Bentham Science Publishers

Access to resources Recommend Favorite

Abeta DNA Vaccination for Alzheimer's Disease: Focus on Disease Prevention

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 2, 2010-01 ,pp. : 207-216

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer’s disease

By Easton Amy   Sankaranarayanan Sethu   Tanghe An   Terwel Dick   Lin Alan   Hoque Nina   Bourin Clotilde   Gu Huidong   Ahlijanian Michael   Bristow Linda  

Psychopharmacology, Vol. 230, Iss. 2, 2013-11 ,pp. : 279-289

Springer Publishing Company

Access to resources Recommend Favorite

Editorial (Thematic Issue: Oxidative Stress as a Pharmacological Target for Medicinal Chemistry: Synthesis and Evaluation of Compounds with Redox Activity - Part 1)

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 22, 2014-11 ,pp. : 2461-2461

Bentham Science Publishers

Access to resources Recommend Favorite